Viewing data from:

LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER

NDA

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | N016679 | BAXTER HEALTHCARE CORP

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

1 petition from Regulations.gov

Petition	Type	Filed	Status	Petitioner
Citizen Petiton from Fresenius Kabi USA, LLC FDA-2017-P-2245 · 5 docket documents Fresenius Kabi USA, LLC filed this citizen petition under 21 CFR 10.20, 10.30, 314.3(b), and section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate Calcium Chloride 20mg/100mL; Dextrose 5g/100mL; Potassium Chloride 30mg/100mL; Sodium Chloride 600mg/100mL; Sodium	505(q)	2017-04-11	Withdrawn	—

Source: Regulations.gov. FDA citizen petitions matched by application number.

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs, 2 NC)

Lowest Price

$25.34

Highest Price

$40.56

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00338-0125-03Lactated Ringer's and 5% Dextrose Inj#2B2073Q	$40.56	NC	Baxter Healthcare Corporation	09/16/2026
00338-0125-04Lactated Ringer's and 5% Dextrose Inj#2B2074X	$25.34	NC	Baxter Healthcare Corporation	09/16/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

4 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.